Skip to main content

Articles Tagged With:

  • Intravascular Ultrasound-Guided PCI

    Gaster et al from Odense University Hospital and the University of Southern Denmark report the results of a randomized, prospective study comparing 5-year major adverse clinical events and cost outcomes after PCI with or without IVUS guidance.
  • Ablation of Ventricular Arrhythmias

    Triggering ventricular premature beats from distal Purkinje fibers or the right ventricular outflow tract are critical initiating factors in patients with VF associated with the long QT and Brugada syndromes. Elimination of these focal triggers can provide relief from recurrent arrhythmias.
  • Pharmacology Watch: Vardenafil Will Compete for Share of ED Market

    The FDA has approved vardenafil (LevitraBayer and GlaxoSmithKline) for the treatment of erectile dysfunction in men. Vardenafil joins sildenafil (Viagra) as the only 2 drugs approved for this indication in this country.
  • A New Genetic Cause of Amyotrophic Lateral Sclerosis

    Genetic investigations have made considerable progress in identifying mutations associated with familial amyotrophic lateral sclerosis (ALS). The identification of genetic alterations in patients with sporadic ALS, however, has lagged behind. The present study is a major advance in investigating the etiology of ALS.
  • Stroke Risk of Inherited Thrombophilia is Low

    This study suggests that the risk conferred by an inherited thrombophilia for ischemic stroke is likely to be low overall and almost nonexistent in some ethnic groups such as individuals of African or African-Caribbean descent.
  • Unraveling Cryptogenic Stroke

    Stroke with no determined cause, or cryptogenic stroke (CS), accounts for nearly 40% of all ischemic strokes. Traditionally, it has been held that CS carries a more benign prognosis than other stroke subtypes. However, until this recent study, the long-term risk of recurrent stroke in this large segment of the stroke population had never been prospectively studied.
  • Clinical Briefs in Primary Care Supplement

    A Strategy to Reduce Cardiovascular Disease by More Than 80 Percent; Pearly Penile Papules: Still No Reason for Uneasiness; The Epidemiology of Major Depressive Disorder; Urinary Tetrahydroaldosterone as a Screen for Aldosteronism; Finasteride and Prostate Cancer; Impermeable Bed Covers in Patients with Allergic Rhinitis
  • Full October 2003 Issue in PDF

  • Pharmacology Watch: Vardenafil Will Compete for Share of ED Market

    The FDA has approved vardenafil (LevitraBayer and GlaxoSmithKline) for the treatment of erectile dysfunction in men. Vardenafil joins sildenafil (Viagra) as the only 2 drugs approved for this indication in this country.
  • Predictive Accuracy of MRI Prognosticators in the Early Detection of Malignant MCA Infarcts

    In the present article, Thomalla and colleagues report on the predictive value of early perfusion-weighted magnetic resonance imaging and diffusion-weighted magnetic resonance imaging within 6 hours of stroke onset in 37 patients with MCA stroke and a proximal vessel occlusion, either the carotid-T or MCA stem.